PD-1/PD-L1 调控系统性红斑狼疮中耗竭 CD8+ T 细胞与记忆 B 细胞的交互作用
研究纳入 104 例系统性红斑狼疮(SLE)患者、225 例其他风湿肌肉骨骼疾病(RMD)患者和 20 名健康对照,比较 QFT 不确定结果率。SLE 组不确定 QFT 结果率为 17.31%,显著高于 RMD 组的 3.56%。SLE 中不确定 QFT 主要由耗竭表型 CD8+ T 细胞 IFN-γ 应答不足所致,PD-1/PD-L1 信号通路调控耗竭 CD8+ T 细胞与活化记忆 B 细胞的交互作用。
要点
- SLE 患者 QFT 不确定结果率为 17.31%,显著高于 RMD 患者的 3.56%。
- QFT 不确定的 SLE 患者疾病活动度更高(SLEDAI-2K 均值 10.94 vs 4.02,p<0.0001),活动性肾炎发生率更高(55.56% vs 29.07%)。
- SLE 中不确定 QFT 主要源于耗竭表型 CD8+ T 细胞 IFN-γ 应答不足,PD-1 激动剂或增加 PD-L1 表达可逆转。
核心结论
- PD-1/PD-L1 信号通路调控耗竭 CD8+ T 细胞与活化记忆 B 细胞之间的交互作用,是 SLE 患者干扰素-γ 应答不足的机制解释。
研究设计与样本
- 研究纳入 2020 年至 2023 年门诊就诊的 104 例 SLE 患者和 225 例其他风湿肌肉骨骼疾病(RMD)患者,20 名健康供者作为对照。
- 所有参与者均进行 QFT,比较各组不确定结果;采用血单核细胞进行免疫表型分析和功能测定。
- 在 QFT 不确定或阴性的 SLE 患者中,于利妥昔单抗治疗前后进行体外和离体干扰素-γ 检测。
主要发现
- 104 例 SLE 患者不确定 QFT 结果率为 17.31%,显著高于 225 例 RMD 患者的 3.56%。
- QFT 不确定的 SLE 患者疾病更活动(SLEDAI-2K 均值 10.94 vs 4.02,p<0.0001),活动性肾炎发生率更高(55.56% vs 29.07%)。
- SLE 中不确定 QFT 主要由耗竭免疫表型的 CD8+ T 细胞 IFN-γ 应答不足所致。
- SLE 中耗竭 PD-1 高表达 CD8+ T 细胞与活化 PD-L1 低表达记忆 B 细胞的异常交互作用可被 PD-1 激动剂或增加 PD-L1 表达所逆转。
- 利妥昔单抗治疗间接逆转了该 IFN-γ 应答。
临床怎么用
- 原文未据此给出推荐。
局限性
- 原文未报告局限性。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
BACKGROUND: Indeterminate readout of the quantitative interferon-γ release test (QFT) for Mycobacterium tuberculosis screening is a specific laboratory finding for systemic lupus erythematosus (SLE), which may be due to T-cell exhaustion and abnormal programmed death receptor 1 (PD-1)/programmed death-ligand 1 (PD-L1) signalling. METHODS: We enrolled 104 patients with SLE and 225 with other rheumatic musculoskeletal diseases (RMDs) who presented to the outpatient clinic between 2020 and 2023. Twenty healthy donors served as the controls. The QFT was performed in all participants, and those with indeterminate results were compared among the groups. Immunophenotyping and functional assays were performed using blood mononuclear cells. Interferon (IFN)-γ was detected in vitro and ex vivo in patients with SLE with indeterminate or negative QFT results, before or after rituximab therapy. RESULTS: 104 patients with SLE had a significantly higher rate of indeterminate QFT results was significantly higher (17.31%) than that of 225 patients with RMD (3.56%). Patients with SLE with indeterminate QFT had more active disease (SLEDAI-2K, mean 10.94 vs 4.02, p<0.0001), including a higher incidence of active nephritis (55.56% vs 29.07%). Indeterminate QFT in SLE is mainly caused by an insufficient IFN-γ response in CD8+T cells with exhausted immunophenotypes. The abnormal interaction between exhausted PD-1 high CD8+ T cells and activated PD-L1 low memory B cells in SLE can be reversed with a PD-1 agonist or increased PD-L1 expression. Rituximab treatment indirectly reversed this IFN-γ response. CONCLUSION: The PD-1/PD-L1 signalling pathway, which governs the crosstalk between exhausted CD8+ T cells and activated memory B cells, is a mechanistic explanation for insufficient interferon-γ response in patients with SLE.
引用
- Wang K, Zhao J, Feng X, et al. PD-1/PD-L1 governed cross-talk of exhausted CD8+ T and memory B cells in systemic lupus erythematosus. RMD Open. 2024. PMID: 38233074. doi:10.1136/rmdopen-2023-003503
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。